Fosinopril monotherapy: Relationship between blood pressure reduction and time of administration-Reference-Cited by-同舟云学术

Fosinopril monotherapy: Relationship between blood pressure reduction and time of administration

Published:1993-04 Issue:4 Volume:16 Page:324-330
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Ford Neville F.,Fulmor I. Edgar,Nichola Peter S.,Alpin Pamela G.,Herron Jarry M.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.4960160407/fullpdf

Reference25 articles.

1. Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models;DeForrest;J Cardiovasc Pharmacol,1990

2. The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension;Waldemar;Am J Hypertens,1990

3. Once-daily fosinopril in the treatment of hypertension;Anderson;Hypertension,1991

4. Relative contribution of the gut, liver, and lung to the first-pass hydrolysis (bioactivation) of orally administered 14C-fosinopril sodium in dogs. In vitro and in vivo studies;Morrison;Drug Metab Dispos,1990

5. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: In vitro and preclinical in vivo pharmacology;DeForrest;J Cardiovasc Pharmacol,1989

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finding inhibitors for PCSK9 using computational methods;PLOS ONE;2021-08-05

2. A Molecular Docking Approach to Evaluate the Pharmacological Properties of Natural and Synthetic Treatment Candidates for Use against Hypertension;International Journal of Environmental Research and Public Health;2019-03-14

3. ACE Inhibitors for the Treatment of Hypertension Drug Selection by Means of the SOJA Method;Reviews on Recent Clinical Trials;2011-01-01

4. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension;Cochrane Database of Systematic Reviews;2008-10-08

5. Physiologic Consequences of Vasopeptidase Inhibition in Humans: Effect of Sodium Intake;Journal of the American Society of Nephrology;2002-10